US Patent Issued to UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION on July 21 for "Treatment of breast cancer with selective androgen receptor modulators and cyclin-dependent kinase 4/6 inhibitors" (American, South Korean Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,719, issued on July 21, was assigned to UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, Tenn.).

"Treatment of breast cancer with selective androgen receptor modulators and cyclin-dependent kinase 4/6 inhibitors" was invented by Mitchell S. Steiner (Germantown, Tenn.), Ramesh Narayanan (Cordova, Tenn.), Sunjoo Ahn (Daejeon, South Korea) and James T. Dalton (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to the treatment of breast cancer in a subject, and the subject can be either a male or female subject. Including methods of: treating metastatic breast cancer; refractory breast cancer; AR-positive brea...